A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's

Clinical trial NCT06309147 · UNKNOWN

Trial details

NCT number: NCT06309147
Sponsor: Allyx Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2024-03-15
Primary completion: 2025-02-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.